Derivative Action Against Depomed as Senate Investigates Opioid Industry Practices

One of the top manufacturers of prescription opioids in the United States is being called out by investors for the company’s alleged role in fuelling the opioid epidemic, which launched a senate investigation and a one-day plummet in the company’s share price.

Read more

Investors Accuse Dialysis Provider DaVita of Ethics Breach

Saying an illegal profit-goosing scheme has already invited regulatory scrutiny and cost dialysis provider DaVita more than a billion dollars in market capitalization, shareholders brought a derivative class action to keep the company in line.

Read more